GR3019289T3 - Steroid sulphatase inhibitors - Google Patents

Steroid sulphatase inhibitors

Info

Publication number
GR3019289T3
GR3019289T3 GR960400692T GR960400692T GR3019289T3 GR 3019289 T3 GR3019289 T3 GR 3019289T3 GR 960400692 T GR960400692 T GR 960400692T GR 960400692 T GR960400692 T GR 960400692T GR 3019289 T3 GR3019289 T3 GR 3019289T3
Authority
GR
Greece
Prior art keywords
steroid sulphatase
sulphatase inhibitors
steroid
inhibitors
thiophosphonates
Prior art date
Application number
GR960400692T
Other languages
English (en)
Inventor
Michael John Reed
Original Assignee
Imperial College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College filed Critical Imperial College
Publication of GR3019289T3 publication Critical patent/GR3019289T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR960400692T 1990-02-21 1996-03-12 Steroid sulphatase inhibitors GR3019289T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909003939A GB9003939D0 (en) 1990-02-21 1990-02-21 Sulphatase inhibitors
PCT/GB1991/000270 WO1991013083A1 (en) 1990-02-21 1991-02-21 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
GR3019289T3 true GR3019289T3 (en) 1996-06-30

Family

ID=10671395

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400692T GR3019289T3 (en) 1990-02-21 1996-03-12 Steroid sulphatase inhibitors

Country Status (12)

Country Link
US (2) US5281587A (el)
EP (1) EP0515544B1 (el)
JP (1) JP3148822B2 (el)
AT (1) ATE133179T1 (el)
AU (1) AU638560B2 (el)
CA (1) CA2069483C (el)
DE (1) DE69116550T2 (el)
DK (1) DK0515544T3 (el)
ES (1) ES2082198T3 (el)
GB (1) GB9003939D0 (el)
GR (1) GR3019289T3 (el)
WO (1) WO1991013083A1 (el)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70665B1 (en) * 1989-11-22 1996-12-11 Whitbread & Co Plc Carbonated beverage container
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
NZ512334A (en) * 1993-01-19 2005-05-27 Endorech Inc Therapeutic methods and delivery systems utilizing sex steroid precursors
WO1995026717A1 (en) * 1994-04-05 1995-10-12 Celltech Therapeutics Limited Use of estrone derivatives as steroid sulphatase inhibitors
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US6642220B1 (en) 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
IL145995A0 (en) * 1999-04-30 2002-07-25 Sterix Ltd Use
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PT1989218E (pt) * 2006-02-17 2010-02-01 Janssen Pharmactuica N V Derivados de 17-fósforo esteróides úteis como moduladores do receptor da progesterona
US7678781B2 (en) * 2006-02-17 2010-03-16 Janssen Pharmaceutica N.V. 11-phosphorous steroid derivatives useful as progesterone receptor modulators
GB0604142D0 (en) 2006-03-01 2006-04-12 Sterix Ltd Compound
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2878157A (en) * 1956-02-29 1959-03-17 Pfizer & Co C Sulfur containing steroid compositions
SU644486A1 (en) * 1970-02-06 1979-01-30 Kh Nii Endokrinologii Khim Gor "proloteston" anti-tumor medicine
GB1527161A (en) * 1976-02-19 1978-10-04 Leo A Enol esters of steroids
AU534679B2 (en) * 1979-03-15 1984-02-09 Commonwealth Scientific And Industrial Research Organisation Steroid immunogens
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors

Also Published As

Publication number Publication date
JPH05503531A (ja) 1993-06-10
EP0515544B1 (en) 1996-01-17
DE69116550T2 (de) 1996-10-24
CA2069483C (en) 2004-01-27
DE69116550D1 (de) 1996-02-29
US5344827A (en) 1994-09-06
JP3148822B2 (ja) 2001-03-26
ATE133179T1 (de) 1996-02-15
US5281587A (en) 1994-01-25
DK0515544T3 (da) 1996-02-12
ES2082198T3 (es) 1996-03-16
WO1991013083A1 (en) 1991-09-05
AU638560B2 (en) 1993-07-01
AU7343591A (en) 1991-09-18
CA2069483A1 (en) 1991-08-22
EP0515544A1 (en) 1992-12-02
GB9003939D0 (en) 1990-04-18

Similar Documents

Publication Publication Date Title
GR3019289T3 (en) Steroid sulphatase inhibitors
AP9400666A0 (en) Benzofuran derivatives.
MX9703564A (es) Inhibidores de proteasa multicatalitica.
GR3026740T3 (en) Alkylsiloxanes as adjuvants for agriculture.
MX9800625A (es) Marcfortinas y paraherquamidas antiparasitarias.
MY102705A (en) Proline derivaties and related compounds.
NO910333L (no) Fremgangsmaate for plasmasprengning.
ZA917096B (en) Enzyme inhibitors
MX9700557A (es) Dihidrobenzofuranos.
MX9700486A (es) Ligando para receptor de cinasa transmembranal de hepatoma.
EP0858262A4 (en) THROMBIN INHIBITORS
AP9400632A0 (en) Ether derivatives.
MY129947A (en) Novel substituted thienopyrans as antihypertensive agents.
AU1097988A (en) Alkylmelatonins
EP0657996A3 (de) Verstärkerstufe.
MY110202A (en) A process for preparing 1-alkylaryl-2-alkyl-5-formylimidazoles
EP0462665A3 (en) Selected 17beta-polyaroyl-4-aza-5alpha-androst-1-en-3-ones as steroidal reductase inhibitors
GB8916289D0 (en) Cofactor for the pam enzyme
DE69108926D1 (de) Oberflächenstabilisierte quellen für isocyanursäure.
UA7130A1 (uk) Імуностимулюючий засіб "тімоген"
JO1770B1 (en) New formulations mainly composed of derivatives of sleepjestrol and the methods necessary to produce them
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
KR100195376B1 (en) Haloethyl-substituted steroid enzyme inhibitors
RO87212B1 (ro) Derivati de p-fluorbenzamida
JO1578B1 (en) Amiphone